Basal cell carcinoma of the maxillofacial region: site distribution and incidence rates in Arab/Jordanians, 1991 to 2000

Rawashdeh, Ma’amon A.; Matalka, Ismail

doi:10.1016/j.joms.2003.04.009

Cited by 12 publications

(15 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The best evidence for increasing BCC incidence with decreasing latitude is seen in North America where the divide between the Northern and Southern states is clear. Rawashdeh and Matalka 60 conducted a U.S.‐standardized BCC incidence study in Jordan from 1991 to 2000 and reported incidence rates of just 8·8/100 000 person‐years (both sexes combined). Jordan lies at a similar latitude to North America.…”

Section: Discussionmentioning

confidence: 99%

A systematic review of worldwide incidence of nonmelanoma skin cancer

Lomas¹,

Leonardi‐Bee²,

Bath‐Hextall

2012

British Journal of Dermatology

1,572

1,220

View full text Add to dashboard Cite

SummaryBackground Nonmelanoma skin cancer (NMSC) is the most common cancer affecting white-skinned individuals and the incidence is increasing worldwide. Objectives This systematic review brings together 75 studies conducted over the past half century to look at geographical variations and trends worldwide in NMSC, and specifically incidence data are compared with recent U.K. cancer registry data. Methods Following the development of a comprehensive search strategy, an assessment tool was adapted to look at the methodological quality of the eligible studies.Results Most of the studies focused on white populations in Europe, the U.S.A. and Australia; however, limited data were available for other skin types in regions such as Africa. Worldwide the incidence for NMSC varies widely with the highest rates in Australia [> 1000 ⁄100 000 person-years for basal cell carcinoma (BCC)] and the lowest rates in parts of Africa (< 1 ⁄100 000 person-years for BCC). The average incidence rates in England were 76AE21 ⁄100 000 personyears and 22AE65 ⁄100 000 person-years for BCC and squamous cell carcinoma (SCC), respectively, with highest rates in the South-West of England (121AE29 ⁄100 000 person-years for BCC and 33AE02 ⁄100 000 person-years for SCC) and lowest rates by far in London (0AE24 ⁄100 000 person-years for BCC and 14AE98 ⁄100 000 person-years for SCC). The incidence rates in the U.K. appear to be increasing at a greater rate when compared with the rest of Europe. Conclusions NMSC is an increasing problem for health care services worldwide. This review highlights a requirement for prevention studies in this area and the issues surrounding incomplete NMSC registration. Registration standards of NMSC should be improved to the level of other invasive disease.

show abstract

Section: Discussionmentioning

confidence: 99%

A systematic review of worldwide incidence of nonmelanoma skin cancer

Lomas¹,

Leonardi‐Bee²,

Bath‐Hextall

2012

British Journal of Dermatology

1,572

1,220

View full text Add to dashboard Cite

show abstract

“…The highest rates are seen in Australia, where over one in two inhabitants will be diagnosed with BCC by the time they are 70 years old, but the increasing incidence in Australia appears to be reaching a plateau, as the rates for people below 60 years of age have stabilized . In non‐Western regions, such as Asia and South America, incidence rates are ten to hundred‐folds lower, but have also increased …”

Section: Incidence Trends and Geographic Differencesmentioning

confidence: 99%

“…7,10,11 In non-Western regions, such as Asia and South America, incidence rates are ten to hundred-folds lower, but have also increased. 12,13 The increase in incidence can be explained by an increased awareness in the general population and among physicians, more surgical treatments (e.g. more excisions with histopathological confirmation instead of cryotherapy or electrodessication), improved registration, an ageing population and changes in the distribution of risk factors such as ultraviolet radiation (UVR) exposure patterns.…”

Section: Incidence Per Region Trends and Differencesmentioning

confidence: 99%

Epidemiology of basal cell carcinoma: scholarly review

et al. 2017

View full text Add to dashboard Cite

Basal cell carcinoma (BCC) is the most common cancer in white-skinned individuals with increasing incidence rates worldwide. Patients with BCC place a large burden on healthcare systems, because of the high incidence and the increased risk of synchronous and metachronous BCCs and other ultraviolet radiation (UVR) related skin cancers (i.e. field cancerization). As a result, the disability-adjusted life years and healthcare costs have risen significantly in recent decades. BCC is a complex disease, in which the interplay between UVR, phenotype (UVR-sensitive) and genotype (somatic mutations and germline mutations/polymorphisms) fulfils a key role in the aetiopathogenesis. Prevention programmes with continual refinements and improvements could be of major importance in tackling the growing skin cancer problem. To provide the most appropriate BCC care, physicians should engage in shared decision-making and choose their treatments wisely.

show abstract

“…Furthermore, the number of probands included in the definitive analysis was limited in comparison with those in other studies . However, similar sample sizes have been reported by other advanced non‐dermatologic care centers in comparable timeframes . Lastly, no immediate frozen sections of resected tumor specimens were prepared and evaluated during surgery.…”

Section: Discussionmentioning

confidence: 99%